Navigation Links
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Date:7/1/2008

h Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has over $250 million under management, and is currently investing out of its third venture capital fund. Among the firm's more than 40 portfolio companies are Arena Pharmaceuticals, NuVasive, Panacos, Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Cerexa (acquired by Forest Laboratories), Syntonix Pharmaceuticals (acquired by Biogen Idec), and CoLucid Pharmaceuticals. For more information, please visit http://www.pappasventures.com.

About Domain Associates

Domain Associates, LLC is a venture capital firm focused on health care product opportunities including biopharmaceuticals, medical devices and related businesses. Over its 20 year history, Domain has been involved in the creation of over 170 companies. Its latest venture capital fund is Domain Partners VI, L.P., which is capitalized at $500 million. Domain is located in Princeton, NJ and in Laguna Niguel, CA. For more information, please visit http://www.domainvc.com.

About Pearl Street Venture Funds

Pearl Street Venture Funds invests in early staged life sciences companies primarily in the biotech, medical device, pharmaceutical and agri-bio sectors. The fund actively seeks therapeutic product companies, "best of breed" enabling technologies and technologies that add value to the drug discovery process. Pearl Street Venture Funds possesses significant life sciences industry experience, venture capital experience and success in advising early stage companies on growth and commercialization strategies, successful exits and syndicating venture deals. For more information, please visit http://www.psvf.com.

About Triathlon Medical Ventures

Triathlon Medical Ventures is a Midwest-based venture c
'/>"/>

SOURCE CoLucid Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... York (PRWEB) September 23, 2014 Mirena ... injury due to spontaneous migration of the birth control ... Bernstein Liebhard LLP reports. According to court documents dated ... that alleges migration of the IUD outside of the ... rectum. Her lawsuit, which is now pending in the ...
(Date:9/23/2014)... 2014 Mel Frank, also known as ... and harvesting marijuana. He is perhaps one of the ... he’ll be leading a special elective course on growing ... pm at Oaksterdam University in Oakland, California. ... nomenclature, harvesting and manicuring, and identifying preflowers and outdoor ...
(Date:9/23/2014)... Florida Hospital Zephyrhills officially celebrates the ... Center on Wednesday, September 24. With more than ... center offers a new level of personalized care ... Health Center offers comprehensive women’s services including gynecology, ... through The Baby Place®, and breast care through ...
(Date:9/23/2014)... TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS ... WHAT: , The National Institutes of Health is convening ... scientific evidence on the long-term effectiveness and potential risks ... among the nation,s top experts in the field of ... well as key NIH scientists who focus on pain ...
(Date:9/23/2014)... (PRWEB) September 24, 2014 From first-hand ... disorder (PTSD) – and how it can be treated. ... deployed in Iraq in 2006. His platoon sustained multiple ... 2008, he was diagnosed with combat-related PTSD and honorably ... was angry, and I had distanced myself from my ...
Breaking Medicine News(10 mins):Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit News: New Complaint Filed On Behalf of Iowa Woman Claims Mirena Migrated to Her Rectum, Bernstein Liebhard LLP Reports 4Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3
... Former Steeler Robin Cole to Appear , , ... be Saturday, August 8, as Experience LEBO and Miller Lite present ... party event, from 8 p.m. to midnight. , , ... to literally party in the street-- Rt. 19/Washington Road closes to vehicular traffic ...
... , FERNDALE, Wash., July 28 Nearly 64 ... vitamin D - a nutrient found to support the immune system, bone strength, ... , manufacturers of a liquid vitamin D3 supplement. , , ... aware that sunscreen, even at SPF15, blocks more than 90 percent of the ...
... , , , ... health care providers and nonprofit health plans, announced today that it ... more than 700 nonprofit agencies nationwide in the second quarter of ... access to high-quality care to uninsured and underserved communities, healthy food ...
... , , LOS ANGELES, ... of next generation digital media protection and intelligence solutions, today ... technology platform to ensure network protection and data security for ... companies, pharmaceutical companies, hospitals, physician practices, and more. In ...
... study by researchers at the Georgetown,s Lombardi Comprehensive Cancer Center ... urine of children with acute lymphoblastic leukemia (ALL), a cancer ... age. The findings are published in the August issue ... caution that these findings should not be seen as cause-and-effect, ...
... , EAST RUTHERFORD, N.J., July 28 Cambrex Corporation (NYSE: CBM ) announced ... closes. , , The Company will host a conference call to discuss the ... Second Quarter 2009 Earnings Conference Call, ... 5, 2009 at 8:30 a.m. Eastern Time, Dial-in: ...
Cached Medicine News:Health News:Mt. Lebanon Comes Alive Saturday, August 8th with ULTRAparty 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 2Health News:Survey Finds 64% of Americans Unaware Sunscreen Inhibits Vitamin D Production 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 2Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 3Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 4Health News:Kaiser Permanente Approves $11 Million in Community Benefit Grants 5Health News:Nexicon Technology to Protect Healthcare Industry 2Health News:Nexicon Technology to Protect Healthcare Industry 3Health News:Nexicon Technology to Protect Healthcare Industry 4Health News:Nexicon Technology to Protect Healthcare Industry 5Health News:Common household pesticides linked to childhood cancer cases in Washington area 2
(Date:9/23/2014)... , Sept. 23, 2014 ... of the "Physician Office Laboratory Markets, 3rd ... This report, Physician Office Laboratory Markets is ... the IVD industry. Physician office laboratories are diverse ... simply perform reimbursable, in-office pregnancy and glucose tests. ...
(Date:9/23/2014)... , Sept. 23, 2014 The Pennsylvania State ... Sat., Sept. 27, as part of National Prescription Drug ... questions asked. Take-Back Day is a national ... Administration (DEA), aimed at encouraging the public to dispose ... prone to abuse and theft. From 10 ...
(Date:9/23/2014)... 23, 2014 Research and Markets ... Vaccine Production Markets" report to their offering. ... and vaccines - including products to treat cancer, diabetes, ... challenges during the final stages of clinical drug testing ... to risk production capital to upscale while anticipating FDA ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3
... Top-line Data to be Released Concurrent with November 9 AHA Data ... ... (Nasdaq: VIAP ), a biotechnology company focused on the development of,compounds ... last patient visit in its Phase 2 acute coronary,syndrome (ACS) study, including ...
... and Efficacy of ORMD 0801, Oral Insulin Capsule, ... on Type 1 ... http://www.oramed.com ), a developer,of oral delivery systems, announced today that it has ... 1 diabetics at the,Hadassah University Medical Center in Jerusalem, Israel., Oramed,s ...
Cached Medicine Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial 4Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
... powder Moisture: 10% Ash: ... gm/cm 2 Gel pH (1.5%): 5.0 7.0 ... 80 95C A (430 nm, 1.5%): ... >= 25,000 Ohms EEO (-m r ): ...
... For the easy and economical generation ... The Hypoxia Incubator Chamber utilizes a surface-type ... are uniformly compressed by a stainless steel ... The cylindrical walls and semi-spherical top and ...
... range of miniTHERM incubators is available, ensuring ... solution for their specific requirements. miniTHERM incubators ... compact and extremely space saving. Their size ... It is possible to stack up to ...
Medicine Products: